Skip to main content
TipRanks
Go Ultimate75% OFF

ImageneBio (IMA) Financial Statements

116 Followers

ImageneBio Financial Overview

ImageneBio's market cap is currently $43.22M. The company's EPS TTM is $-3.11; its P/E ratio is -1.11; ImageneBio has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 800.00K$ 3.50M$ 9.16M$ 15.62M$ 30.98M
Gross Profit$ -233.00K$ 1.97M$ 8.14M$ -48.70M$ -16.12M
Operating Income$ -48.45M$ -37.00M$ -75.42M$ -70.90M$ -34.14M
EBITDA$ -44.67M$ -35.03M$ -67.31M$ -68.01M$ -33.57M
Net Income$ -45.35M$ -36.57M$ -68.17M$ -68.77M$ -34.12M
Balance Sheet
Cash & Short-Term Investments$ 75.78M$ 124.39M$ 175.47M$ 156.95M$ 232.22M
Total Assets$ 152.98M$ 141.51M$ 192.09M$ 172.26M$ 247.88M
Total Debt$ 9.99M$ 7.52M$ 10.74M$ 5.69M$ 6.99M
Net Debt$ -24.97M$ -31.87M$ -109.16M$ -54.23M$ -225.23M
Total Liabilities$ 19.84M$ 15.58M$ 22.34M$ 25.29M$ 40.00M
Stockholders' Equity$ 133.14M$ 125.93M$ 169.76M$ 146.97M$ 207.88M
Cash Flow
Free Cash Flow$ -47.84M$ -46.00M$ -80.16M$ -75.54M$ -62.01M
Operating Cash Flow$ -47.84M$ -46.00M$ -79.74M$ -74.11M$ -60.25M
Investing Cash Flow$ -5.81M$ -34.90M$ 64.14M$ -99.28M$ -1.76M
Financing Cash Flow$ 135.47M$ 0.00$ 75.98M$ 1.09M$ 131.74M

Currency in USD

ImageneBio Earnings and Revenue History

-80M-40M040M-6000 %-4000 %-2000 %0 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin

ImageneBio Liabilities to Assets

0100M200M300M0 %120 %240 %360 %LiabilitiesLiabilities to Assets20182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

ImageneBio Cash Flow

-150M-100M-50M050M100M150M20182019202020212022202320242025OperatingInvestingFinancing

ImageneBio Forecast EPS vs Actual EPS

-4-3-2-10Q2 25Q3 25Q4 25Q2 26Q3 26EPS EstimateBeatMiss